Can Delta Variant Effectiveness Fill Brazil-Sized Hole In Bharat Biotech’s Prospects?

Ocugen Class Action Suit Could Get Tricky

 
• By Vibha Ravi
  
Covaxin vial
Bharat Biotech's Global Ambitions For Covaxin Have Landed It In Trouble • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip